Early treatment with infliximab for Crohn's disease patients

被引：0
|
作者：
de Chambrun, G. Pineton [1 ]
Libier, L. [2 ]
Nachury, M. [2 ]
Collins, M. [3 ]
Koriche, D. [4 ]
Gower-Rousseau, C. [5 ]
Zerbib, P. [4 ]
Cortot, A. [6 ]
Colombel, J. -F. [7 ]
Desreumaux, P. [2 ]
机构：
[1] Univ Montpellier I, Gastroenterol & Hepatol, Montpellier, France
[2] CHU Lille, Dept Gastroenterol, Lille, France
[3] APHP Paris Sud Univ, Gastroenterol, Le Kremlin Bicetre, France
[4] Lille Univ Hosp, Dept Colorectal Surg, Lille, France
[5] North France Univ, Lille Univ Hosp, Epidemiol, Lille, France
[6] North France Univ, Lille Univ Hosp, Gastroenterol, Lille, France
[7] Mt Sinai Hosp, Gastroenterol, New York, NY 10029 USA
来源：
JOURNAL OF CROHNS & COLITIS | 2015年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P346
引用
收藏
页码：S251 / S252
页数：2
相关论文
共 50 条
  • [41] Infliximab treatment for symptomatic Crohn's disease strictures
    Pelletier, A. -L.
    Kalisazan, B.
    Wienckiewicz, J.
    Bouarioua, N.
    Soule, J. -C.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (03) : 279 - 285
  • [42] The Dutch guidelines for treatment with infliximab for Crohn's disease
    Vermeire, S.
    NETHERLANDS JOURNAL OF MEDICINE, 2006, 64 (07): : 210 - 211
  • [43] Treatment of luminal and fistulizing Crohn's disease with infliximab
    Comerford, LW
    Bickston, SJ
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2004, 33 (02) : 387 - +
  • [44] Treatment of pyoderma gangrenosum with Infliximab in Crohn's disease
    Sapienza, MS
    Cohen, S
    DiMarino, AJ
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (09) : 1454 - 1457
  • [45] Managing immunogenic responses to infliximab - Treatment implications for patients with Crohn's disease
    Han, PD
    Cohen, RD
    DRUGS, 2004, 64 (16) : 1767 - 1777
  • [46] Safety and cost of infliximab for the treatment of belgian pediatric patients with Crohn's disease
    De Greef, E.
    Hoffman, I.
    D'Haens, G.
    Van Biervliet, S.
    Smets, F.
    Scaillon, M.
    Dewit, O.
    Peeters, H.
    Paquot, I.
    Alliet, P.
    Arts, W.
    Hauser, B.
    Vermeire, S.
    Van Gossum, A.
    Rahier, J. F.
    Etienne, I.
    Louis, E.
    Coche, J. C.
    John, J. Mahachie
    Van Steen, K.
    Veereman, G.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2012, 75 (04) : 425 - 431
  • [47] Infliximab treatment decreases serum osteoprotegerin concentration in patients with Crohn's disease
    Miheller, Pal
    Muzes, Gyorgyi
    Racz, Karoly
    Blazovits, Anna
    Lakatos, Peter
    Herszenyi, Laszlo
    Tulassay, Zsolt
    GASTROENTEROLOGY, 2007, 132 (04) : A364 - A364
  • [48] Profile of infliximab in the treatment of pediatric Crohn's disease
    Kierkus, Jaroslaw
    Szymanska, Edyta
    Oracz, Grzegorz
    Wiernicka, Anna
    Dadalski, Maciej
    PEDIATRIC HEALTH MEDICINE AND THERAPEUTICS, 2015, 6 : 79 - 85
  • [49] Infliximab in treatment of Crohn's disease: the Milan experience
    Ardizzone, S
    Colombo, E
    Maconi, G
    Bollani, S
    Manzionna, G
    Petrone, MC
    Porro, GB
    DIGESTIVE AND LIVER DISEASE, 2002, 34 (06) : 411 - 418
  • [50] Treatment of severe esophageal Crohn's disease with infliximab
    Heller, T
    James, SP
    Drachenberg, C
    Hernandez, C
    Darwin, PE
    INFLAMMATORY BOWEL DISEASES, 1999, 5 (04) : 279 - 282
12345